Skip to main content

CORRECTION article

Front. Cell. Neurosci. , 08 August 2023

Sec. Cellular Neuropathology

Volume 17 - 2023 | https://doi.org/10.3389/fncel.2023.1267913

Corrigendum: Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody

This article is a correction to:

  1. Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody

    1. Read original article
\r\nFlorine Seidel,Florine Seidel1,2Kees FluiterKees Fluiter3Robert KleemannRobert Kleemann1Nicole WormsNicole Worms1Anita van NieuwkoopAnita van Nieuwkoop1Martien P. M. CaspersMartien P. M. Caspers4Nikolaos GrigoriadisNikolaos Grigoriadis5Amanda J. KiliaanAmanda J. Kiliaan2Frank BaasFrank Baas3Iliana Michailidou&#x;Iliana Michailidou5†Martine C. Morrison &#x;Martine C. Morrison1*†
  • 1Department of Metabolic Health Research, Netherlands Organisation for Applied Scientific Research (TNO), Leiden, Netherlands
  • 2Department of Medical Imaging, Anatomy, Preclinical Imaging Center (PRIME), Radboud Alzheimer Center, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Center, Nijmegen, Netherlands
  • 3Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands
  • 4Department of Microbiology and Systems Biology, Netherlands Organisation for Applied Scientific Research (TNO), Leiden, Netherlands
  • 5Laboratory of Experimental Neurology and Neuroimmunology and the Multiple Sclerosis Center, 2nd Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece

A corrigendum on
Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody

by Seidel, F., Fluiter, K., Kleemann, R., Worms, N., van Nieuwkoop, A., Caspers, M. P. M., Grigoriadis, N., Kiliaan, A. J., Baas, F., Michailidou, I., and Morrison, M. C. (2023). Front. Cell. Neurosci. 17:1205261. doi: 10.3389/fncel.2023.1205261

In the published article there was an error. A correction has been made to the Acknowledgments section. This sentence previously stated:

“We would like to thank the biotechnicians from TNO Metabolic Health Research for taking excellent care of the mice used in this study.”

The corrected sentence appears below:

“We would like to thank the biotechnicians from TNO Metabolic Health Research for taking excellent care of the mice used in this study. We also thank B. P. Morgan and T. Hughes for kindly providing the BB5.1 antibody.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: obesity, aging, brain, neurodegeneration, astrogliosis, neuroinflammation, anti-complement component 5

Citation: Seidel F, Fluiter K, Kleemann R, Worms N, van Nieuwkoop A, Caspers MPM, Grigoriadis N, Kiliaan AJ, Baas F, Michailidou I and Morrison MC (2023) Corrigendum: Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody. Front. Cell. Neurosci. 17:1267913. doi: 10.3389/fncel.2023.1267913

Received: 27 July 2023; Accepted: 28 July 2023;
Published: 08 August 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Seidel, Fluiter, Kleemann, Worms, van Nieuwkoop, Caspers, Grigoriadis, Kiliaan, Baas, Michailidou and Morrison. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Martine C. Morrison, bWFydGluZS5tb3JyaXNvbkB0bm8ubmw=

†These authors have contributed equally to this work and share last authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

Man ultramarathon runner in the mountains he trains at sunset

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more